BioCentury
ARTICLE | Clinical News

Doryx doxycycline hyclate delayed-release tablet regulatory update

April 22, 2013 7:00 AM UTC

FDA approved a 200 mg dose of tetracycline oral antibiotic Doryx doxycycline hyclate delayed-release tablet from Mayne's U.S. marketing partner Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland). War...